EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitZurückgezogene PublikationOpen Access · CC BY 4.0

RETRACTED: The Impact of Fusobacterium nucleatum and the Genotypic Biomarker KRAS on Colorectal Cancer Pathogenesis

Ahmed Dewan iD, Ivan Tattoli, Maria Teresa Mascellino iD

International Journal of Molecular Sciences · 20.07.2025 · 26 (14) · 6958

DOI: 10.3390/ijms26146958 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 20.07.2025. Verfasst von Ahmed Dewan und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences, Anhui Agriculture University, Hefei 230036, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Fusobacterium nucleatum, Proto-Oncogene Proteins p21(ras), Biomarkers, Tumor. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fusobacterium nucleatum and activating mutations in the Kirsten rat sarcoma virus oncogene homolog (KRAS) are increasingly recognized as cooperative drivers of colorectal cancer (CRC). F. nucleatum promotes tumorigenesis via adhesion to epithelial cells, modulation of the immune microenvironment, and delivery of virulence factors, while KRAS mutations—present in 60% of CRC cases—amplify proliferative signaling and inflammatory pathways. Here, we review the molecular interplay by which F. nucleatum enhances KRAS-driven oncogenic cascades and, conversely, how KRAS mutations reshape the tumor niche to favor bacterial colonization. We further discuss the use of KRAS as a prognostic biomarker and explore promising non-antibiotic interventions—such as phage therapy, antimicrobial peptides, and targeted small-molecule inhibitors—aimed at selectively disrupting F. nucleatum colonization and virulence. This integrated perspective on microbial–genetic crosstalk offers novel insights for precision prevention and therapy in CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsFusobacterium nucleatumProto-Oncogene Proteins p21(ras)Biomarkers, TumorFusobacterium InfectionsHumansAnimalsMutationTumor MicroenvironmentGenotype

Stichwörter der Autor:innen

FadAFap2Fusobacterium nucleatumKRAS mutationsbacteriophage therapycolorectal cancermicrobiome–genotype interplaynon-antibiotic microbiome modulationtargeted therapy resistance

Substanzen

Proto-Oncogene Proteins p21(ras)KRAS protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • College of Life Sciences, Anhui Agriculture University, Hefei 230036, China.
  • Department of Translational and Precision Medicine, Sapienza University of Rome, 00185 Rome, Italy.
  • Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.

ORCID-Profile: Ahmed Dewan, Maria Teresa Mascellino

Zitieren

APA

Dewan, A., Tattoli, I., & Mascellino, M. T. (2025). RETRACTED: The Impact of Fusobacterium nucleatum and the Genotypic Biomarker KRAS on Colorectal Cancer Pathogenesis. International Journal of Molecular Sciences, 26(14), 6958. https://doi.org/10.3390/ijms26146958

Vancouver

Dewan A, Tattoli I, Mascellino MT. RETRACTED: The Impact of Fusobacterium nucleatum and the Genotypic Biomarker KRAS on Colorectal Cancer Pathogenesis. International Journal of Molecular Sciences. 2025;26(14):6958. doi:10.3390/ijms26146958

BibTeX
@article{Dewan2025,
  author = {Dewan, Ahmed and Tattoli, Ivan and Mascellino, Maria Teresa},
  title = {RETRACTED: The Impact of Fusobacterium nucleatum and the Genotypic Biomarker KRAS on Colorectal Cancer Pathogenesis},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {14},
  pages = {6958},
  doi = {10.3390/ijms26146958}
}
Kostenlos starten →